Arvetas Biosciences

Entelexo Biotherapeutics, based in Irvine, CA, is pioneering a novel class of therapeutic exosomes designed to address complex autoimmune diseases such as Rheumatoid Arthritis, Crohn's Disease, and Psoriasis. Utilizing a proprietary engineering platform, the company develops exosomes that communicate with multiple specific cell types simultaneously, aiming to provide more effective and personalized treatment options. Since its founding in 2020, Entelexo has rapidly progressed through various developmental milestones, including the formation of a Scientific Advisory Board and completion of drug candidate development. The company's approach focuses on analyzing patient data to optimize product efficacy, representing a significant advancement in tailoring treatments that align with the intricate nature of autoimmune disorders. Generated from the website

Accelerating growth of the biomedical industry via an open innovation platform that provides economical wet lab and office space, valuable technical resources, and a network of strategic partnerships

Ajk Biopharmaceutical LLC, founded in 2018 and based in Irvine, California, is a biotech research company dedicated to developing innovative transfecting agents that enhance the delivery of small interfering RNA (siRNA) into living cells. The company focuses on creating a novel cyclic peptide platform technology aimed at providing cost-effective solutions for therapeutic delivery challenges faced by pharmaceutical companies. Partum Biopharma's mission is to leverage its expertise in peptide chemistry to significantly improve siRNA delivery, demonstrating in vivo transformation of siRNA within cells. Through strategic partnerships and collaborations, the company aims to facilitate effective transfection methods across diverse cell lines while ensuring cell viability. Generated from the website